10 deaths a day as S. Korea's suicide fight falls short among seniors
An average of nearly 10 older South Koreans died by suicide every day between 2019 and 2023, according to a sobering new report that underscores the growing mental health crisis among the country's aging population.
In total, 18,044 seniors aged 65 and older took their own lives during that five-year period, amounting to over 3,000 deaths each year, the report said. The findings, published in the Journal of the Korean Medical Association and authored by Dr. Oh Dae-jong of the Workplace Mental Health Institute at Kangbuk Samsung Hospital, point to the urgent need for improved suicide prevention efforts targeting vulnerable seniors in South Korea.
In 2023 alone, the suicide mortality rate — the number of deaths per 100,000 people —stood at 40.6 among seniors, 45 percent higher than the rate of 28 observed among people aged 15 to 64.
"Older adults are less likely than younger people to seek psychiatric help before attempting suicide, and many take their own lives after only one or a few attempts, making early identification of high-risk seniors important," Oh wrote in the report.
Depression in older adults is often driven by factors such as the loss of a spouse, financial stress, loneliness, family conflict as well as a lingering sense of guilt over being a burden on their families — all of which can deepen suicidal thoughts.
Alongside mental health conditions, chronic physical illnesses are also major contributors to suicide among older adults. The risk of suicide rises significantly in the period shortly after a diagnosis.
Compared to younger people, older adults tend to use more fatal means of suicide, such as ingesting pesticides or hanging, making survival much less likely.
'It is essential to have trained gatekeepers across the medical field who can identify and respond to early verbal, emotional and behavioral warning signs in older adults at risk of suicide. Effective suicide prevention requires a comprehensive, collaborative strategy between health professionals and the community," the report stressed.
Meanwhile, the country's senior population surpassed the 10 million mark for the first time last November, reaching 10.12 million, an increase of 513,000 from a year earlier, according to Statistics Korea.
Older adults now account for 19.5 percent of the total population of 51.81 million, up from 18.6 percent the previous year, indicating that some 1 in 5 Koreans are now 65 or older.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
05-08-2025
- Korea Herald
Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics
SEOUL, South Korea, Aug. 5, 2025 /PRNewswire/ -- Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) designed to advance laboratory automation and data-driven infectious disease monitoring. The company introduced CURECA™, world's first fully unattended PCR automation system, and STAgora™, a real-time data analytics platform intended to support earlier detection and precision care. Chairman Highlights Next Step in Molecular Diagnostics "With CURECA™ and STAgora™, we are taking an important step toward the future of diagnostics," said Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, during a press conference with U.S. and global media on July 30. "Our goal is to enable laboratories worldwide to automate complex testing workflows and use diagnostic data more effectively, ultimately helping advance global efforts toward a world free from diseases." Today, most molecular testing systems remain only partially automated, dependent on skilled personnel for repetitive manual steps and fixed workflows that limit efficiency and scalability. CURECA™ Breaks the Limits of Automation to Reshape Global Diagnostics CURECA™ is the first system in the diagnostics industry designed to fully automate every step of PCR testing, including the traditionally manual pre-treatment stage. Seegene notes that achieving true full automation in diagnostics requires three key conditions: operation without highly trained professionals, continuous 24-hour processing, and uninterrupted specimen input. CURECA™ is designed to meet all three. Its dedicated module, CURECA™ Prep, processes a wide range of specimen types such as urine, blood, sputum, and stool, addressing one of the most persistent barriers to automation. With the module handling diverse specimen pre-treatment, the full CURECA™ system completes the entire PCR workflow from sample loading through nucleic acid extraction, amplification, and result analysis without manual intervention. The system is engineered for continuous 24-hour operation, aiming to minimize human error, improve workflow efficiency, and allow laboratories to allocate skilled staff to higher-value activities. Full automation has long been a challenge in diagnostics due to specimen variability and the reliance on trained personnel for repetitive pre-processing tasks. CURECA™ is intended to help laboratories overcome these constraints by providing a scalable and adaptable system that can be configured to fit different lab sizes and workflows. CURECA™ Prep could also potentially extend to other testing fields, such as clinical chemistry and immunodiagnostics, as Seegene continues to explore broader automation solutions. STAgora™ Transforms Diagnostic Data into Real-Time Clinical Intelligence STAgora™ is Seegene's latest platform, designed to collect and analyze PCR testing data in real time, providing laboratories with broader context to inform diagnostic workflows. The platform includes more than 40 analytical tools, offering functions such as infection trend tracking, hospital-level positivity monitoring, and multi-pathogen co-infection pattern analysis. Rather than serving as a simple data repository, STAgora™ is built as an integrated platform intended to help laboratories derive meaningful, aggregated insights from testing data. Today, individual test results often provide limited information without broader reference points. STAgora™ is designed to address this by enabling hospitals to build their own statistical datasets and compare aggregated data across institutions, helping them detect infection patterns faster and support more informed decision-making. The data shared through the platform is de-identified and formatted according to each institution's requirements, supporting secure, real-time exchange at local, national, or global levels. Advancing Toward a World Free from All Diseases Dr. Chun reiterated Seegene's long-term vision of building "a world free from diseases" noting that the introduction of CURECA™ and STAgora™ completes the company's five core technology pillars. These include Seegene's proprietary PCR technology, the SGDDS (Seegene Digitalized Development System) for automated assay development, its global Technology-Sharing Initiative, and now the addition of fully automated PCR testing and real-time data analytics capabilities. Industry experts at ADLM 2025 expressed strong interest in Seegene's new technologies. Jamel Giuma, President and CEO of Miami based laboratory IT consulting firm JTG Consulting Group, said, "I've attended many ADLM conferences over the years, and CURECA™ is one of the most innovative solutions I have seen so far. I believe it has the potential to simplify laboratory workflows, reduce the burden on lab personnel, and greatly enhance overall operational efficiency." "With CURECA™ and STAgora™, we're addressing long-standing barriers in molecular diagnostics," Dr. Chun added. "Just as smartphones and electric vehicles transformed their industries, we believe these technologies will redefine what is possible in diagnostic testing, helping laboratories worldwide achieve true automation, unlock the value of diagnostic data, and ultimately contribute to building a world free from diseases." Disclaimer CURECA™ and STAgora™ demonstrated at ADLM 2025 are pre-commercial technologies under development, not commercially available, and are not currently cleared for clinical diagnostic use in any jurisdiction.
Korea Herald
05-08-2025
- Korea Herald
South Korea pays just a quarter of US drug prices: report
Prescription drug prices in South Korea are among the lowest in the developed world, with Koreans paying just 25.6 percent of what Americans pay on average for the same medicines, according to new data released by the Korea Biotechnology Industry Organization. The analysis, published Monday by KoreaBIO's Bio-Economic Research Center, compares 2022 prescription drug prices across 33 OECD member countries. Based on a February 2024 study by the RAND Corporation, supported by the US Department of Health and Human Services and using IQVIA MIDAS data, the report confirms what many in the industry have long suspected: South Korea remains one of the most affordable countries in the world for pharmaceuticals. On average, drug prices in the US are 3.9 times higher than in South Korea. For brand-name drugs, the gap grows to 7 times. Among the top 60 revenue-generating medicines in the US, prices are 8.4 times higher. Biologics are also significantly more expensive, costing over 5.7 times more than in Korea. The report also highlighted US price premiums over other major markets: 3.5 times higher than Japan, 3.3 times higher than France, 2.9 times higher than Germany, and 2.7 times higher than the United Kingdom. Turkey showed the greatest disparity, with US drug prices more than 10 times higher than those in Turkey. The report comes days after US President Donald Trump issued letters to 17 global pharmaceutical firms demanding that they lower US prices to match the 'most favored nation' level, referring to the lowest price charged in any OECD country. The companies have been given a 60-day deadline to respond.
Korea Herald
03-08-2025
- Korea Herald
10 deaths a day as S. Korea's suicide fight falls short among seniors
With few visible signals, more fatal methods, senior suicides underscore need for tailored mental health interventions, report finds An average of nearly 10 older South Koreans died by suicide every day between 2019 and 2023, according to a sobering new report that underscores the growing mental health crisis among the country's aging population. In total, 18,044 seniors aged 65 and older took their own lives during that five-year period, amounting to over 3,000 deaths each year, the report said. The findings, published in the Journal of the Korean Medical Association and authored by Dr. Oh Dae-jong of the Workplace Mental Health Institute at Kangbuk Samsung Hospital, point to the urgent need for improved suicide prevention efforts targeting vulnerable seniors in South Korea. In 2023 alone, the suicide mortality rate — the number of deaths per 100,000 people —stood at 40.6 among seniors, 45 percent higher than the rate of 28 observed among people aged 15 to 64. "Older adults are less likely than younger people to seek psychiatric help before attempting suicide, and many take their own lives after only one or a few attempts, making early identification of high-risk seniors important," Oh wrote in the report. Depression in older adults is often driven by factors such as the loss of a spouse, financial stress, loneliness, family conflict as well as a lingering sense of guilt over being a burden on their families — all of which can deepen suicidal thoughts. Alongside mental health conditions, chronic physical illnesses are also major contributors to suicide among older adults. The risk of suicide rises significantly in the period shortly after a diagnosis. Compared to younger people, older adults tend to use more fatal means of suicide, such as ingesting pesticides or hanging, making survival much less likely. 'It is essential to have trained gatekeepers across the medical field who can identify and respond to early verbal, emotional and behavioral warning signs in older adults at risk of suicide. Effective suicide prevention requires a comprehensive, collaborative strategy between health professionals and the community," the report stressed. Meanwhile, the country's senior population surpassed the 10 million mark for the first time last November, reaching 10.12 million, an increase of 513,000 from a year earlier, according to Statistics Korea. Older adults now account for 19.5 percent of the total population of 51.81 million, up from 18.6 percent the previous year, indicating that some 1 in 5 Koreans are now 65 or older.
